Application 212262
- Type
- ANDA
- Sponsor
- SUNGEN PHARMA
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | METHYLPREDNISOLONE | METHYLPREDNISOLONE | TABLET;ORAL | 4MG | No | No |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 70625-237 | METHYLPREDNISOLONE | methylprednisolone | SunGen Pharma LLC | ANDA | Current |
| 70625-237 | METHYLPREDNISOLONE | methylprednisolone | Praxgen Pharmaceuticals LLC | ANDA | Current |
| 70625-237 | METHYLPREDNISOLONE | methylprednisolone | Praxgen Pharmaceuticals LLC | ANDA | Current |
| 72647-331 | METHYLPREDNISOLONE | methylprednisolone | OAKRUM PHARMA, LLC | ANDA | Current |
| 72647-331 | METHYLPREDNISOLONE | methylprednisolone | OAKRUM PHARMA, LLC | ANDA | Current |
| 72647-331 | METHYLPREDNISOLONE | methylprednisolone | OAKRUM PHARMA, LLC | ANDA | Current |
| 72647-331 | METHYLPREDNISOLONE | methylprednisolone | OAKRUM PHARMA, LLC | ANDA | Current |
| 72647-331 | METHYLPREDNISOLONE | methylprednisolone | OAKRUM PHARMA, LLC | ANDA | Current |